Prognosis of breast cancer during pregnancy: evidence for nursing care by Fernandes, Ana Fátima Carvalho et al.
Rev.  Latino-Am. Enfermagem
2011 Nov.-Dec.;19(6):1453-61
www.eerp.usp.br/rlae
Review Article
Corresponding Author: 
Cristina Maria Galvão
Universidade de São Paulo. Escola de Enfermagem de Ribeirão Preto
Departamento de Enfermagem Geral e Especializada
Av. dos Bandeirantes, 3900
Bairro: Monte Alegre
CEP: 14040-902, Ribeirão Preto, SP, Brasil
E-mail: crisgalv@eerp.usp.br
Prognosis of breast cancer during pregnancy: evidence for 
nursing care
Ana Fátima Carvalho Fernandes1
Míria Conceição Lavinas Santos2
Tiago Barreto de Castro e Silva3
Cristina Maria Galvão4
This integrative review analyzed evidence available in the literature concerning the prognosis 
of breast cancer during pregnancy. The following databases were used for selecting studies: 
PubMed, CINAHL and LILACS. A total of 240 primary studies were identified; 13 papers 
were included in the integrative review’s sample after reading the titles and abstracts and 
according to the established inclusion and exclusion criteria. There is evidence indicating 
that pregnancy does not worsen the evolution of breast cancer and a poor prognosis is 
related to late stage tumors. Among the gaps identified in the studied theme, the need for 
further studies addressing nursing care provided to pregnant women with breast cancer is 
highlighted in order to promote improved care in the context of health care.
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O prognóstico de câncer de mama na gravidez: evidências para o 
cuidado de enfermagem
O presente estudo teve como objetivo analisar as evidências disponíveis na literatura 
sobre o prognóstico de câncer de mama na gravidez. O método de revisão adotado foi 
a revisão integrativa. Para a seleção dos estudos primários, utilizaram-se as bases de 
dados PubMed, CINAHL e LILACS. Na busca, foram identificados 240 estudos primários, 
após a leitura dos títulos e resumos e, frente aos critérios de inclusão e exclusão 
estabelecidos, 13 artigos foram incluídos na amostra da revisão integrativa. Na síntese 
do conhecimento produzido, há evidências que indicam que a gestação não piora a 
evolução do câncer de mama e o mau prognóstico está relacionado ao estadiamento 
tardio do tumor. Dentre as lacunas identificadas, sobre o tópico investigado, destaca-se 
a necessidade de condução de estudos direcionados para a assistência de enfermagem, 
prestada à mulher grávida, com câncer de mama, para promover a melhoria do cuidado 
no contexto da atenção à saúde.
Descritores: Neoplasias da Mama; Gravidez; Prognóstico; Enfermagem.
El pronóstico de cáncer de mama en el embarazo: evidencias para la 
atención de enfermería
Esta revisión integradora de la literatura objetivó analizar las evidencias disponibles en 
la literatura sobre el pronóstico del cáncer de mama durante el embarazo. La selección 
de los estudios primarios fue realizada en las bases de datos PubMed, CINAHL y LILACS; 
se identificaron 240 estudios primarios. Después de la lectura de los títulos y resúmenes 
y establecimiento de los criterios de inclusión y exclusión, 13 artículos fueron incluidos 
en la muestra de la revisión integradora. En la síntesis del conocimiento producido hay 
evidencias que indican que el embarazo no empeora la evolución del cáncer de mama y 
el pronóstico malo está relacionado con la estadificación clínica tardía del tumor. Entre 
las lagunas en el tópico investigado hay que resaltar la necesidad de realizar estudios 
sobre la atención de enfermería prestada a mujeres embarazadas con cáncer de mama 
para mejoría del cuidado en el contexto de la atención a la salud.
Descriptores: Neoplasias de la Mama; Embarazo; Pronóstico; Enfermería.
Introduction
One of the problems that most seriously affects 
women in all aspects of life is the diagnosis of breast 
cancer, which is probably the most feared diagnosis 
among the female population given its increased 
incidence and the psychological and social impact it 
causes, especially due to the atmosphere of fear and 
taboo that surround such a disease(1).
According to estimates published by the Brazilian 
Cancer Institute (INCA), the number of new cases of 
breast cancer expected for Brazil in 2010 is 49,240, 
with an estimated risk of 49.27 cases/100,000 women. 
The estimates present a total of 8,270 new cases for 
the northeast: 550 new cases are estimated to be 
diagnosed in Paraiba and 210 in the capital of the state, 
which amounts to raw rates of 28.68/100,000 and 
59.34/100,000, respectively(2).
Conducting studies in this context is relevant, 
especially studies producing evidence to fill in gaps of 
knowledge concerning the issue, specifically pregnancy-
associated breast cancer (PABC), which is addressed in 
this study.
PABC is every breast cancer diagnosed during 
pregnancy or up to one year after birth. The first reports 
of this disease, date to more than a hundred years 
ago and had a poor prognosis. The first researchers 
published a case series and after five years of follow-up, 
all patients died(3).
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A study published in 1999 indicated that breast 
cancer accounts for 0.2% to 3.8% of all cancers affecting 
women during pregnancy, with a ratio from 1/3,000 to 
1/10,000 pregnancies(4). Another study reported that 
depending on the country, some case series presented 
an association of 1/2,000 pregnancies(5). PABC is the 
second most frequent cause of neoplasia associated with 
pregnancy, surpassed only by cervical cancer(4,6).
Over the course of our careers, we have developed 
activities with groups of women with cancer, including 
women who were undergoing treatment and became 
pregnant or who became pregnant after a cancer 
diagnosis and those who within five years due to the 
pathology. From this experience emerged the need to 
research the prognosis of PABC.
Given the preceding discussion, we believe this 
study provides support based on the results of studies 
that can help decision-making of nurses aiming to 
improve care provided to women with breast cancer.
Objective
To analyze evidence available in the literature on 
the prognosis of PABC.
Method
Evidence-based practice (EBP) involves the 
definition of a problem, the search for and critical 
evaluation of available evidence, implementation of 
evidence in practice and evaluation of the results obtained. 
The clinical expertise of professionals and patients’ 
preferences are aspects that are also incorporated into 
the EBP for decision-making concerning health care(7).
The method chosen to achieve the proposed 
objective in this study was an Integrative Review (IR), 
which considerably contributes to strengthening EBP.
The following stages were followed: identification 
of the theme or development of the guiding question, 
sampling or search of studies in the literature, 
categorization of studies, evaluation of studies included 
in the review, discussion and interpretation of results, 
and synthesis of knowledge found in the analyzed papers 
or the presentation of the integrative review’s results(8).
The guiding question used in this integrative review 
was: “What is the evidence available in the literature 
concerning the prognosis of PABC?”
The following databases were used to search 
for primary studies: PUBMED-MEDLINE (Medical 
Literature Analysis and Retrieval System on-line), 
CINAHL (Cumulative Index to Nursing and Allied Health 
Literature) and LILACS (Latin-American and Caribbean 
Health Sciences).
The controlled and non-controlled descriptors (key 
words) selected for the primary studies search are 
listed in Figure 1, which were combined and/or modified 
in each database according to the need to ensure a 
comprehensive search.
Figure 1 – Controlled and non-controlled descriptors 
according to the selected databases
Databases Controlled descriptors Non-controlled descriptors
PUBMED
Pregnancy
Breast cancerBreast neoplasms
Prognosis
LILACS
Pregnancy
Breast cancerBreast neoplasms
Prognosis
CINAHL
Breast neoplasms
Breast cancerPrognosis
Pregnancy
Inclusion criteria to select primary studies were: 
papers addressing breast cancer during pregnancy, 
published in English, Spanish or Portuguese in the last 
ten years (January 2000 up to April 2010). Literature 
reviews or narrative reviews and editorials were 
excluded.
Primary studies were selected by title and abstract 
according to the study’s objective and adopted inclusion 
and exclusion criteria. A total of 178 papers were pre-
selected from PUBMED, 26 from LILACS, and 36 from 
CINAHL, totaling 240 papers.
A total of 26 papers were drawn from those primary 
studies pre-selected from PUBMED after a fresh reading, 
from which 17 were excluded. Hence, nine papers 
from this database were included in the review. Only 
two papers from the 26 pre-selected from LILACS were 
included. Six primary studies were identified in CINAHL 
but they were all excluded. Therefore, the IR sample 
was composed of 13 papers, which were fully analyzed.
A data collection instrument proposed and validated 
by Ursi(9) was used to extract data. Concepts proposed 
by researchers from the nursing field were used to 
analyze the studies’ design and level of evidence of the 
primary studies included in the review(10-11)..
The analysis and synthesis of the primary studies 
were performed in a descriptive form, allowing readers 
to evaluate the quality of evidence (level of evidence) 
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available in the literature concerning the investigated 
theme, support decision-making in daily nursing care 
provided to patients with PABC and also identify gaps of 
knowledge for the development of future research.
Results
Ten out of the 13 papers included in the review were 
published in English, two in Portuguese and one in Spanish. 
Publications originated from many different countries and 
the Irish Medical Journal stood out with two papers.
In relation to papers’ level of evidence: seven 
primary studies presented level of evidence IV, that 
is, case-control studies; five studies presented level 
of evidence VI: one descriptive, two case series, one 
retrospective and a case study; one study presented 
level of evidence VII: expert opinion. Figure 2, 3 and 
4 present an abstract of each paper included in the IR 
and Figure 5 presents the synthesis of primary studies 
concerning the investigated outcome (prognosis).
Study Objective Result Conclusion
Gelber et al.(12)
To evaluate the impact of a 
pregnancy subsequent to diagnosis 
on the prognosis of patients with 
breast cancer in its initial stage.
The survival of women who became 
pregnant was greater than that of the 
compared group, for whom the five-
year survival rate was 85% ± 3% and 
ten-year survival rate was 74% ± 4%. 
Pregnancy subsequent to diagnosis 
did not adversely affect the prognosis 
of breast cancer in its initial stage. 
The greater survival observed 
in this study and in others may 
merely reflect a selection bias of 
healthy patients, though it is also 
consistent with the antitumor effect of 
pregnancy.
Mottola-Junior et al.(13)
To study 15 cases of PABC and 
compare them with a control group 
of young patients with invasive 
ductal carcinoma, evaluating 
the clinical stage, axillary lymph 
node involvement, nuclear grade, 
histological tumor grade, and 
hormone receptors for estrogen and 
progesterone.
In relation to disease-free survival 
and global survival: nine patients 
(60%) were alive and free of disease, 
four patients (26.6%) were alive 
with the disease, and two (13.4%) 
patients died. A statistically significant 
difference was found for the worst 
clinical stage (p=0.0022) and greater 
axillary lymph node involvement 
(p=0.0017) in pregnant women.
There was no difference when 
pregnant women were compared 
to non-pregnant women within the 
same age range in relation to the 
prognosis of PABC.
Reed et al.(14)
To evaluate prognosis factors in 
173 patients with breast cancer 
subdivided into  three groups: 
subsequent group, pregnancy group 
and breastfeeding group.
None of the studied parameters were 
significant predictors of prognosis 
when compared to breastfeeding + 
pregnancy versus subsequent group. 
Being 35 years old or younger was 
an unfavorable prognosis factor only 
for the breastfeeding + pregnancy 
groups. Five-year survival was 40%, 
41% and 86% in the pregnancy, 
breastfeeding and subsequent 
groups respectively. 
The results demonstrated that 
breastfeeding (birth 1-12 months 
before the breast cancer diagnosis) 
and pregnancy (birth 0-9 months 
after diagnosis) groups were 
very similar in relation to clinical-
pathological parameters compared 
to the subsequent group (birth more 
than 9 months after diagnosis), with 
larger tumors, greater histological 
classification, negative status 
for hormonal receptors and high 
positivity for c-erb-2.
Aziz et al.(15)
To measure the various tumor 
markers (p53, C-erb-2, EGFR, 
Cathepsin-D, PCNA, DNA ploidy 
and S-phase fraction) jointly with 
the development of the disease in 
patients with PABC compared to a 
control group.
All the patients (case and control 
groups) had been diagnosed with 
infiltrating ductal carcinoma. No 
statistically significant difference was 
found in relation to global survival of 
tested patients and the control group, 
if compared stage by stage. 
Malignant neoplasms of the breast 
may not be noticed for varying 
periods of time, which gives them 
a chance to increase in size before 
detection, leading to a larger 
tumor size found in PABC patients. 
Additionally, lymph nodes metastasis 
is common in these patients, again 
due to a delay in diagnosing it, which 
directly affects the prognosis.
(continue...)
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Figure 2 – Synthesis of studies with level of evidence IV (case-control)
Study Objective Result Conclusion
Makgasa et al.(16)
To evaluate the experience of a 
facility specializing in breast cancer 
treatment in the north of Ireland in 
dealing with PABC.
The average age of PABC patients 
was 36.58 years old and that of 
those in the control group was 37.96. 
Eleven PABC patients presented 
localized disease;  one presented 
bone metastasis; one had bloody 
breast discharge; and all the 
remaining presented a palpable 
lump. The average time of pregnancy 
at the time of the diagnosis was 15.5 
weeks. All the patients underwent 
surgery and all PABC patients had a 
moderate to poor clinical prognosis 
according to the Nottingham 
Prognostic Index.
The poor diagnosis for PABC 
patients may be related to a late 
diagnosis or delayed search for 
services. Another hypothesis is 
that the biology of PABC patients is 
inherently more aggressive. In fact, 
the PABC patients belatedly sought 
for health care and the disease 
was already advanced when the 
prognosis is usually poor. 
Halaska et al.(17)
To describes the epidemiology, 
treatment and development of 
women diagnosed with PABC or 
within one year after pregnancy.
No statistically significant difference 
was found in relation to survival rate 
comparing the PABC group and the 
control group (non-pregnant women) 
(p=0.449).
Stage by stage, the prognosis of 
breast cancer is similar if comparing 
PABC women and non-PABC 
women, though poorer diagnoses 
in the postpartum should be 
investigated. 
Beadle et al.(18)
To compare the rates of locoregional 
recurrence, metastases and survival 
in young patients (35 years old or 
younger) who developed PABC to 
non-PABC women.
No statistically significant difference 
was found between PABC and 
non-PABC women in relation to 
rates of locoregional recurrence, 
distant metastasis rates and ten-
year survival. A greater proportion 
of lymph vascular invasion was 
observed in the PABC group while 
no statistically significant differences 
were found within this group (cancer 
during or up to one year after 
pregnancy).
The fact that PABC patients present 
a more advanced stage suggests 
that the greater risk for this group 
results from a delayed diagnosis 
since the pregnancy by itself 
does not imply a poor diagnosis. 
A pregnancy may, however, mask 
the symptoms and hinder an early 
diagnosis. 
Author Study design Objective Results Conclusion
Peralta-
Musre(19) Descriptive study
To describe the profile of 
women enrolled in a breast 
pathology unit from a 
gynecological and obstetrical 
service in a hospital in relation 
to pregnancy and breast cancer.
Three-, four-, or ten-year 
disease-free survival was lower 
than that of non-pregnant 
women.
PABC prognosis is usually poor.
Hill et al.(20) Case series
To analyze the clinical evolution 
of 12 women with PABC history.
In the analysis of clinical 
evolution of the studied cases: 
five patients died and two 
already had metastatic disease 
at the time of diagnosis. Median 
of survival was 31 months. 
There were three stillbirths: one 
therapeutic abortion and two 
during chemotherapy treatment.
A PABC diagnosis is difficult 
and usually occurs in advanced 
stages. Surgery may safely be 
performed during pregnancy 
and adjuvant chemotherapy 
should not be postponed until 
postpartum
Grossmann et 
al.(21) Retrospective study
To retrospectively evaluate 86 
surgical specimens of women 
who underwent surgery and 
were cared for in the Institute of 
Tumors in Milan between 1977 
and 1991 and their relationship 
to relative risk of death through 
the variables: tumor, nodes, age.
The results show the level 
of statistical significance for 
the variables of association 
by order of importance: 
histological classification of 
tumor size, axillary lymph node 
histopathologic classification 
and age.
Based on the studied variables, 
the authors concluded that 
the use of the product of the 
variables tumor histopathologic 
classification, number of 
involved axillary lymph nodes 
and age permit predicting with 
statistical significance relative 
risk of death for each patient 
with breast neoplasm during 
pregnancy. 
(continue...)
(continuation)
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Figure 3 – Synthesis of studies with level of evidence VI
(continuation)
Author Study design Objective Results Conclusion
Martínez-
Ramos et 
al.(22)
Case study
To describe a case of a 34 
years old woman, in the 28th 
week of pregnancy, who sought 
the health service given a lump 
in the right breast.
After clinical exams and biopsy, 
the patient was diagnosed with 
breast cancer and underwent 
a Madden modified radical 
mastectomy. The patient 
underwent a C-section in the 
32nd week and began later the 
usual chemotherapy treatment.
The authors state that PABC 
is a frequent and common 
disease but not exceptional. 
They highlight the importance 
of a high rate of early detection 
of breast lumps, which leads to 
early diagnosis, consequently 
improving the patient’s 
prognosis. 
Khairy, Al-
Abdulkarim(23) Case series
To describe the clinical evolution 
of five women with PABC.
Three patients were diagnosed 
in the first trimester of pregnancy 
and two postpartum (two weeks 
and 9 months later). One of 
them underwent therapeutic 
abortion. One patient was 
diagnosed in stage II and four in 
stage III. All patients presented 
some lymph node involvement 
but none were diagnosed with 
metastatic disease. All women 
were treated with adjuvant 
chemotherapy after surgery. 
One died. 
Diagnosing PABC is difficult 
because physiological changes 
during this period hinder its 
detection. Greater attention 
should be paid toward improving 
care standards, especially in 
regions where the diagnosis is 
usually delayed.
Figure 4 – Synthesis of study with level of evidence VII
Study Expert opinion Conclusion / Recommendations
Loibl et al.(24) Report of an expert committee concerning PABC.
The objective of treatment provided to PABC women is the same as that provided 
to non-pregnant women: local control of the disease and prevention of metastases. 
However, certain types of treatment need to be modified given the potential 
adverse effects posed to the fetus.  There is evidence that supports the safe use of  
chemotherapeutic anthracycline during the second and third trimesters of pregnancy 
(level of evidence Oxford 2b). Due to a lack of evidence concerning the routine use 
of new cytotoxic drugs such as taxanes, experts did not recommend their use during 
pregnancy.
Year Authors Outcome
2001 Gelber et al.(12) There are no adverse effects of pregnancy subsequent to diagnosis in the prognosis of PABC women and there is evidence that a pregnancy may be actually associated to a more favorable prognosis.
2001 Peralta-Musre(19) The prognosis of PABC is usually unfavorable due to delay in diagnosis and treatment. The studied patients presented lower five-year survival than non-pregnant women.
2002 Hill et al.(20) Even though stage-by-stage prognosis is similar, PABC has a worse general prognosis than when breast cancer does not occur in this period; delay in diagnosing the disease may contribute to it. 
2002 Mottola- Júnior et al.(13)
PABC has a poor prognosis and no differences were found when non-pregnant women within the same 
age range were compared with PABC women. The determinant factor for survival is the advanced clinical 
stage at the time of diagnosis.
2002 Grossmann et al.(21)
Young pregnant and non-pregnant women with breast cancer tend to have a worse prognosis than 
premenopausal or postmenopausal women. Axillary involvement is an important element in staging and 
prognosis.
2003 Reed et al(14) The authors state that PABC prognosis is poor, though the reasons for that are still unknown. Also, the shorter the time between cancer diagnosis and a previous pregnancy, the worse the prognosis.
2003 Aziz et al(15) The results did not present a statistically significant difference between the PABC group and the control group in regard to survival and late staging. 
(continue...)
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Figure 5 – Synthesis of primary studies concerning studied outcome (prognosis)
Discussion
From the synthesis of evidence of the primary 
studies included in the review concerning the prognosis 
of PABC, we stress that nine out of the 13 studies 
included indicate that a poor prognosis is associated to 
late stage tumors(13-15,16-17,20-23).
A previous study had already indicated that poor 
prognoses are related to the time between the breast 
cancer diagnosis and pregnancies preceding the 
diagnosis(25). One recent study also indicates that one 
of the issues that complicate the prognosis of breast 
cancer during pregnancy is a delayed diagnosis(26). 
Poor prognoses are partially explained by the tendency 
of pregnant women to be in more advanced stages 
of the disease at the time of the diagnosis. Still, that 
does not seem to be the only explanation since there 
is also a study indicating that the pregnancy itself is an 
independent factor for a worse prognosis(27).
A study published in 1999 reports that the survival 
of patients in the stages II or III was 75%, suggesting 
that with modern therapy and multidisciplinary help, the 
prognosis would not be so poor as once believed(4). On 
the other hand, in two studies included in the integrative 
review, the results did not show statistically significant 
difference concerning survival rate in a comparison 
between PABC women and the control group (non-
pregnant women)(17-18).
The authors of another study claim that pregnancy 
hormones would be responsible for a worse prognosis. 
Pregnancy is characterized by a significant increase of 
estrogen, IGF-1, progesterone and prolactin, which in 
turn are closely related to the etiology of breast cancer 
and its development. These hormones promote the 
growth of tumor cells responsive to hormones(28).
It became clear in cell culture that the increase of 
hormone concentrations during pregnancy can increase 
the proliferation of cancer cells and tumor size. Another 
hypothesis that would explain the high mortality of 
pregnant women with breast cancer is that pregnancy 
hormones select tumors with a worse prognosis. But 
there are few studies addressing the topic(29-31).
An immunohistochemistry study conducted over 
more than 700 cases of breast cancer reported that 
tumors of women who had recently gave birth did not 
differ in size, staging or receptors of estrogen and 
HER2 but did present more progesterone receptor-
negative, positive p53 and a greater histological degree. 
Hence, progesterone receptor-negative seems to be 
associated with a worse prognosis, in part because it is 
less sensitive to tamoxifen and also because it confers 
an invasive phenotype on the tumor cells in a model 
system. A greater expression of p53 in pregnant women 
with breast cancer is also consistent in the selection of 
more aggressive tumors during pregnancy(29).
There is evidence in the literature indicating that 
a pregnancy does not worsen the evolution of breast 
cancer, according to five primary studies included in the 
review(12,15,22-24). The authors report that the prognosis 
of PABC women does not seem to differ from that of 
non-pregnant women within the same age range and 
who are at the same disease stage. These results are 
corroborated by two other studies(32-33). Two studies in 
the review indicate a poor prognosis for breast cancer 
Year Authors Outcome
2006 Loibl et al.(24) The authors state that the prognosis for PABC patients does not seem to differ from that of non-pregnant women within the same age range and stage of disease.
2007 Martínez-Ramos et al.(22)
The authors claim that the poor prognosis of PABC women is probably related to the advanced tumor 
stage at the time of diagnosis and state that the prognosis of these women is similar to that of non-
pregnant women when compared by age and tumor stage. Five-year survival is approximately 60% when 
there are no lymph node metastases and 45% when nodes are not affected. 
2008 Khairy, Al-Abdulkarim(23) The authors indicate that a worse prognosis frequently occurs given a late diagnosis. Stage-by-stage prognosis of PABC is similar to that of non-pregnant women. 
2009 Makgasa et al.(16) This study demonstrated that PABC is presented with large tumors with significant involvement of lymph nodes and moderate to poor prognosis.
2009 Halaska et al.(17) Based on the case series, the authors assert there was a tendency toward a worse prognosis when PABC was diagnosed within a year after birth. 
2009 Beadle et al.(18)
Poorer prognoses related to breast cancer are much more related to the young age of patients than to 
pregnancy. Patients with PABC do not have a poor prognosis if diagnosed during pregnancy or within one 
year postpartum. 
(continuation)
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patients when associated with young age, stating that 
young women with breast cancer, pregnant or not, tend 
to have a worse prognosis(18,21).
One of the aspects that complicate the prognosis 
of PABC is a delayed diagnosis. In this context, one 
should take into account the physiological changes 
caused by the pregnancy in the mammary glands 
related to consistency and density, which may mask 
the disease’s signs and symptoms and hinder a precise 
interpretation of screening exams, delaying diagnosis 
and consequently reducing the rates of the survival of 
these women(26). It is common in professional practice 
to encounter painless lumps that can go unnoticed due 
to the breasts’ increased volume and engorgement. 
Hence, the nurses’ preparedness to perform physical 
assessments, especially of the breasts during prenatal 
care and postpartum, is a relevant element that can 
contribute to the early detection of PABC.
The studied problem may be a result of 
inappropriate care that presents gaps mainly in prenatal 
care. Quality and humanized prenatal and postpartum 
care is essential for the health of mother and child. For 
care to be qualified and humanized, one has to look at 
the health-disease continuum from a new perspective 
and understand the person in her totality of body and 
mind and also consider the social, economic, cultural and 
physical environment where she is inserted. Moreover, 
new bases should be established for the relationships 
of those involved in the production of health: health 
professionals, users and managers(34).
It is the role of nurses to implement integral and 
multidisciplinary care for women experiencing breast 
cancer during pregnancy, intensifying continuous 
and individualized evaluation during prenatal care, 
acknowledging the participation of women and families 
in decision-making concerning the treatment and 
maintenance of pregnancy, and considering ethical, 
religious, psychological, organic and legal aspects(35).
Conclusion
The synthesis of knowledge produced in this 
integrative review indicates there is evidence in the 
literature that a pregnancy does not worsen the evolution 
of breast cancer and that the poor diagnosis is related 
to the late stage tumors. However, given the reduced 
number of papers included in the analysis and their level 
of evidence (IV, VI and VII) further studies addressing 
the topic are needed.
The conduct of this integrative review reinforced the 
importance of early diagnosis, which can contribute to 
an improved prognosis for PABC women. In this context, 
we highlight the role of nurses since the results from this 
review support decision-making of nurses concerning 
the planning and implementation of interventions in 
nursing care provided to this population.
Nurses working with care delivered to women at all 
levels of care need to implement strategies to intensify 
preventive actions and the early detection of breast 
cancer, especially during pregnancy, and develop actions 
directed to primary care. The qualification of nurses to 
perform physical assessments, especially of breasts 
during prenatal and postpartum care, is a relevant 
contribution to the early detection of PABC.
Among the required actions, we highlight health 
education actions in which nurses should encourage 
an active role of women using the health services, 
stimulating breast self-examination. Nursing has a 
preponderant role in developing actions jointly with the 
population since the focus of its work is humanized care, 
centered on disease prevention of and health promotion.
Finally, among the gaps identified in the studied 
topic, we underscore the need to conduct studies 
addressing nursing care provided to PABC women in 
order to promote improved health care.
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